loadpatents
name:-0.039741039276123
name:-0.022413969039917
name:-0.028738021850586
NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD. Patent Filings

NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD..The latest application filed is for "a single-domain antibody for targeting prostate specific membrane antigen (psma)".

Company Profile
30.33.44
  • NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD. - Beer-Sheva IL
  • NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD - Beer-Sheva IL
  • The National Institute for Biotechnology in the Negev Ltd. - Beersheba N/A IL
  • THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV, LTD. -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
A Single-domain Antibody For Targeting Prostate Specific Membrane Antigen (psma)
App 20220306764 - PAPO; Niv ;   et al.
2022-09-29
Biomarkers for diagnosis of lung cancer
Grant 11,408,887 - Shoshan-Barmatz August 9, 2
2022-08-09
Il-2 Chimeric Proteins For Immunosuppression
App 20220213163 - PORGADOR; Angel
2022-07-07
Delivery Peptides And Methods Of Using The Same
App 20220204563 - KHALAILA; Isam ;   et al.
2022-06-30
Kits, Compositions And Methods For Evaluating Immune System Status
App 20220196677 - Monsonego; Alon ;   et al.
2022-06-23
Compositions For Inoculating Aquatic Animals
App 20220174914 - MIZRAHI; Itzhak ;   et al.
2022-06-09
Biomarkers Of Chronic Lymphocytic Leukemia And Use Thereof
App 20220170114 - SHOSHAN-BARMATZ; Varda
2022-06-02
Antibodies With Reduced Immunogenicity
App 20220127349 - HERTZ; Tomer ;   et al.
2022-04-28
Biomarkers of chronic lymphocytic leukemia and use thereof
Grant 11,286,533 - Shoshan-Barmatz March 29, 2
2022-03-29
Means And Methods For Reducing Tumorigenicity Of Cancer Stem Cells
App 20220056456 - SHOSHAN-BARMATZ; Varda
2022-02-24
Vdac Inhibitors For Treating Autoimmune Diseases
App 20220023381 - SHOSHAN-BARMATZ; Varda ;   et al.
2022-01-27
Fusion Proteins With Extended Serum Half Life
App 20220023388 - PORGADOR; Ari-Angel ;   et al.
2022-01-27
Vdac Inhibitors For Treating Inflammatory Bowel Diseases
App 20220023382 - SHOSHAN-BARMATZ; Varda
2022-01-27
Compositions And Methods For Treatment Of Bone Associated Diseases
App 20210403514 - PAPO; Niv ;   et al.
2021-12-30
Vdac1 Silencing Molecules And Use Thereof
App 20210395752 - SHOSHAN-BARMATZ; Varda
2021-12-23
Means and methods for reducing tumorigenicity of cancer stem cells
Grant 11,174,484 - Shoshan-Barmatz November 16, 2
2021-11-16
Fusion proteins with extended serum half life
Grant 11,141,463 - Porgador , et al. October 12, 2
2021-10-12
Smac/diablo Inhibitors Useful For Treating Cancer
App 20210261965 - SHOSHAN-BARMATZ; Varda ;   et al.
2021-08-26
Compositions and methods for treatment of bone associated diseases
Grant 11,098,091 - Papo , et al. August 24, 2
2021-08-24
Compositions Comprising Hydroxycinnamic Acid And Related Conjugates, Analogues And Derivatives, And Methods Of Use Thereof
App 20210144999 - KOLODKIN-GAL; Ilana ;   et al.
2021-05-20
Methods For Treating Diabetes Using Vdac1 Inhibitors
App 20210130291 - SALEHI; Albert ;   et al.
2021-05-06
ANALOGUES OF VDAC1-DERlVED PEPTIDES
App 20210079052 - SHOSHAN-BARMATZ; Varda
2021-03-18
Methods for treating central nervous system disorders using vdac inhibitors
Grant 10,946,013 - Shoshan-Barmatz , et al. March 16, 2
2021-03-16
Novel Piperazine And Piperidine Derivatives, Their Synthesis And Use Thereof In Inhibiting Vdac Oligomerization, Apoptosis And Mitochondria Dysfunction
App 20210040047 - SHOSHAN-BARMATZ; Varda ;   et al.
2021-02-11
Anti-pcna Monoclonal Antibodies And Use Thereof
App 20210032320 - PORGADOR; Ari-Angel
2021-02-04
Tumor Environment-specific Expression Of Chimeric Antigen Receptors
App 20210030799 - PORGADOR; Angel ;   et al.
2021-02-04
Anti-PCNA monoclonal antibodies and use thereof
Grant 10,836,818 - Porgador November 17, 2
2020-11-17
Analogues of VDAC1-derived peptides
Grant 10,829,530 - Shoshan-Barmatz November 10, 2
2020-11-10
Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction
Grant 10,787,423 - Shoshan-Barmatz , et al. September 29, 2
2020-09-29
Biomarkers Of Chronic Lymphocytic Leukemia And Use Thereof
App 20200270701 - SHOSHAN-BARMATZ; Varda
2020-08-27
Method Of Selecting Ruminating Animals For A Desirable Hereditable Trait
App 20200248237A1 -
2020-08-06
Peptide Kinase Inhibitors And Methods Of Use Thereof
App 20200231642 - Livneh; Etta ;   et al.
2020-07-23
Biomarkers For Diagnosis Of Lung Cancer
App 20200173998 - SHOSHAN-BARMATZ; Varda
2020-06-04
Novel Piperazine And Piperidine Derivatives, Their Synthesis And Use Thereof In Inhibiting Vdac Oligomerization, Apoptosis And M
App 20200115348 - SHOSHAN-BARMATZ; Varda ;   et al.
2020-04-16
Anti-pcna Monoclonal Antibodies And Use Thereof
App 20200031910 - PORGADOR; Ari-Angel
2020-01-30
Methods For Treating Central Nervous System Disorders Using Vdac Inhibitors
App 20200000801 - SHOSHAN-BARMATZ; Varda ;   et al.
2020-01-02
Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction
Grant 10,508,091 - Shoshan-Barmatz , et al. Dec
2019-12-17
ANALOGUES OF VDAC1-DERlVED PEPTIDES
App 20190375808 - Shoshan-Barmatz; Varda
2019-12-12
Methods for treating central nervous system disorders using VDAC inhibitors
Grant 10,434,099 - Shoshan-Barmatz , et al. O
2019-10-08
Fusion Proteins With Extended Serum Half Life
App 20190255150 - PORGADOR; Ari-Angel ;   et al.
2019-08-22
Analogues of VDAC1-derived peptides
Grant 10,385,104 - Shoshan-Barmatz A
2019-08-20
Compositions And Methods For Treatment Of Bone Associated Diseases
App 20190248845 - PAPO; Niv ;   et al.
2019-08-15
Non-cytotoxic Modified Cells And Use Thereof
App 20190233516 - MONSONEGO; Alon ;   et al.
2019-08-01
Variants of DR3 and use thereof
Grant 10,308,703 - Aharoni , et al.
2019-06-04
VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAIN
App 20180362616 - PAPO; Niv ;   et al.
2018-12-20
Means And Methods For Reducing Tumorigenicity Of Cancer Stem Cells
App 20180327753 - SHOSHAN-BARMATZ; Varda
2018-11-15
ANALOGUES OF VDAC1-DERlVED PEPTIDES
App 20180134760 - SHOSHAN-BARMATZ; Varda
2018-05-17
Novel Piperazine And Piperidine Derivatives, Their Synthesis And Use Thereof In Inhibiting Vdac Oligomerization, Apoptosis And Mitochondria Dysfunction
App 20180118700 - SHOSHAN-BARMATZ; Varda ;   et al.
2018-05-03
Methods for Treating Central Nervous System Disorders Using VDAC Inhibitors
App 20180078548 - SHOSHAN-BARMATZ; Varda ;   et al.
2018-03-22
IL-17R-ECD mutants and methods of using same
Grant 9,850,294 - Aharoni , et al. December 26, 2
2017-12-26
Short peptides derived from VDAC1, compositions and methods of use thereof
Grant 9,758,559 - Shoshan-Barmatz September 12, 2
2017-09-12
Molecular diagnostic kits for evaluating stress
Grant 9,664,690 - Monsonego , et al. May 30, 2
2017-05-30
Variants Of Dr3 And Use Thereof
App 20170114118 - AHARONI; Amir ;   et al.
2017-04-27
Cationic Polysaccharides For Delivery Of Phosphoinositides To Cells For Therapeutic Purpose
App 20170049900 - Kost; Joseph ;   et al.
2017-02-23
Novel Il-17r-ecd Mutants
App 20160376343 - AHARONI; AMIR ;   et al.
2016-12-29
IL-17R-ECD mutants and methods of using same
Grant 9,416,168 - Aharoni , et al. August 16, 2
2016-08-16
Covalent inhibition of bacterial quorum sensing
Grant 9,242,951 - Meijler , et al. January 26, 2
2016-01-26
Thermo-conductive reaction plate holder
Grant 8,871,161 - Guttman , et al. October 28, 2
2014-10-28
Methods For Diagnosing Cancer
App 20140186837 - Shoshan-Barmatz; Varda
2014-07-03
Covalent Inhibition Of Bacterial Quorum Sensing
App 20140073690 - MEIJLER; Michael M. ;   et al.
2014-03-13
Covalent inhibition of bacterial quorum sensing
Grant 8,501,969 - Meijler , et al. August 6, 2
2013-08-06
Photoreactive compound specifically binding to calcium binding proteins
Grant 8,034,314 - Shoshan-Bar-Matz , et al. October 11, 2
2011-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed